文献速递心血管US

低强度脉冲超声在心血管疾病中的研究热点与临床转化前景

Low-Intensity Pulsed Ultrasound in Cardiovascular Diseases: Research Hotspots and Clinical Translation Prospects.
PubMed 文献 · Ultrasound Med Biol · 2026-08-12

该研究基于Web of Science和Scopus数据库,采用文献计量学分析与系统综述相结合的方法,梳理低强度脉冲超声(LIPUS)在心血管疾病中的应用。结果显示中国发文量居首,研究主要集中于血管生成机制、心肌梗死和代谢调节。LIPUS在缺血性心脏病和代谢性心肌病中显示出抗炎、促血管生成和心脏保护作用,初步临床研究提示其用于冠状动脉和外周动脉疾病的潜力。

要点

  • LIPUS主要处于动物研究阶段,临床证据有限,阅片医生需甄别文献中的证据等级。
  • 现有研究聚焦缺血性心脏病与代谢性心肌病,关注抗炎、促血管生成和心脏保护效应。
  • 初步临床研究提示LIPUS可用于冠状动脉和外周动脉疾病,但尚需大规模试验验证。

核心结论

  • LIPUS在心血管疾病中显示出抗炎、促血管生成和心脏保护作用,主要证据来自动物研究。
  • 该领域正从基础研究向临床探索过渡,初步临床研究提示其用于冠状动脉和外周动脉疾病的潜力。

研究设计与样本

  • 研究类型为结合文献计量学分析与系统综述的研究,不涉及原始患者或动物样本。
  • 数据来源于Web of Science和Scopus数据库,分析维度包括发文趋势、合作网络和关键词共现。

诊断标准与关键数值

  • 原文未报告敏感度、特异度、AUC、诊断阈值或分级标准等定量指标。

临床应用与阅片要点

  • 当前LIPUS在心血管疾病中的证据多为动物实验,不宜直接作为临床影像诊断或疗效判断依据。
  • 关注后续大规模临床试验的影像终点设置,如心肌活性、灌注或血管通畅指标的变化。
  • 对于涉及LIPUS治疗随访的病例,需谨慎解读影像改变与临床结局之间的关系。

局限性

  • 当前证据主要来自动物研究,临床试验数量有限。
  • 国际合作有限,主要产出国为中国、日本和巴西,跨区域合作不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Cardiovascular diseases (CVDs) represent a significant global health challenge. Low-intensity pulsed ultrasound (LIPUS), a non-invasive therapeutic approach, has emerged as a promising modality for promoting tissue repair, reducing inflammation, and improving microcirculation. This study employs a combination of bibliometric analysis and a systematic research review to outline the evolving landscape of LIPUS applications in cardiovascular disease. Relevant literature was comprehensively retrieved from the Web of Science and Scopus databases. Analytical insights were derived from publication trends, collaborative networks, and keyword mapping. The findings indicate that China currently leads in research output, followed by Japan and Brazil, though international collaboration remains limited. Current research on LIPUS in CVDs primarily focuses on angiogenesis mechanisms, myocardial infarction, and metabolic regulation, with evidence largely derived from animal studies. These investigations have established its anti-inflammatory, pro-angiogenic, and cardioprotective benefits in conditions such as ischemic heart disease and metabolic cardiomyopathy. Preliminary clinical studies also indicate its therapeutic potential for coronary and peripheral artery disease. Overall, the field is transitioning from foundational research toward clinical exploration. To advance translational progress, future efforts should foster cross-regional collaboration, integrate mechanistic and clinical inquiries, and prioritize larger-scale trials in understudied cardiovascular conditions to facilitate broader clinical implementation.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Wang, Wang, Yu, et al. Low-Intensity Pulsed Ultrasound in Cardiovascular Diseases: Research Hotspots and Clinical Translation Prospects. Ultrasound Med Biol. 2026. PMID: 42580953. doi:10.1016/j.ultrasmedbio.2026.07.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。